IppocraTech Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3.14M

  • Investors
  • 6

IppocraTech General Information

Description

Developer of a remote patient monitoring device designed to track the vital signs of individuals with chronic health conditions. The company's technology allows medical professionals and individuals to monitor vitals like blood pressure, heart rate, and oxygen saturation remotely, enabling patients to assess their health.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Via Carlo Zucchi 21/D
  • 41123 Modena
  • Italy
+39 351
Primary Industry
Monitoring Equipment
Other Industries
Clinics/Outpatient Services
Outcome Management (Healthcare)
Vertical(s)
Corporate Office
  • Via Carlo Zucchi 21/D
  • 41123 Modena
  • Italy
+39 351

IppocraTech Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IppocraTech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 01-Jan-2025 $3.14M Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Accelerator/Incubator 15-Apr-2023 Completed Generating Revenue
3. Later Stage VC 05-Apr-2023 Completed Generating Revenue
2. Accelerator/Incubator 06-Oct-2022 Completed Generating Revenue
1. University Spin-Out 01-Jan-2017 Completed Startup
To view IppocraTech’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

IppocraTech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IppocraTech Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Tech and Biomedical Foundation Venture Capital Minority
Intesa Sanpaolo Corporation
Fintech Partners Venture Capital Minority
Up2Stars Accelerator/Incubator
University of Modena and Reggio Emilia University
You’re viewing 5 of 6 investors. Get the full list »

IppocraTech FAQs

  • When was IppocraTech founded?

    IppocraTech was founded in 2017.

  • Where is IppocraTech headquartered?

    IppocraTech is headquartered in Modena, Italy.

  • What is the size of IppocraTech?

    IppocraTech has 9 total employees.

  • What industry is IppocraTech in?

    IppocraTech’s primary industry is Monitoring Equipment.

  • Is IppocraTech a private or public company?

    IppocraTech is a Private company.

  • What is IppocraTech’s current revenue?

    The current revenue for IppocraTech is .

  • How much funding has IppocraTech raised over time?

    IppocraTech has raised $6.9M.

  • Who are IppocraTech’s investors?

    Tech and Biomedical Foundation, Intesa Sanpaolo, Fintech Partners, Up2Stars, and University of Modena and Reggio Emilia are 5 of 6 investors who have invested in IppocraTech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process